Literature DB >> 24917739

Prostate specific antigen: the past, present and future.

Harcharan Gill1, Jonathan Wu1.   

Abstract

AIM: To review current data available on use of prostate specific antigen for screening healthy men for prostate cancer.
METHODS: Literature was reviewed and the guidelines from, American cancer Society, American Urologic Association was reviewed.
RESULTS: Current screening protocols lead to over diagnosis of prostate cancer. This often results in unnecessary biopsy procedures and treatments.
CONCLUSION: We must consider the benefit of screening and treatment with the harms of over diagnosis and over treatment. Newer imaging modalities like magnetic resonance imaging have to be evaluated further.

Entities:  

Keywords:  Prostate cancer; Prostate-specific antigen; Screening

Year:  2013        PMID: 24917739      PMCID: PMC3783281          DOI: 10.1159/000343535

Source DB:  PubMed          Journal:  Curr Urol        ISSN: 1661-7649


  23 in total

1.  PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume.

Authors:  Eric J Whitman; Jack Groskopf; Amina Ali; Yongmei Chen; Amy Blase; Bungo Furusato; Gyorgy Petrovics; Mona Ibrahim; Sally Elsamanoudi; Jennifer Cullen; Isabell A Sesterhenn; Stephen Brassell; Harry Rittenhouse; Shiv Srivastava; David G McLeod
Journal:  J Urol       Date:  2008-09-17       Impact factor: 7.450

2.  Role of MRI in minimally invasive focal ablative therapy for prostate cancer.

Authors:  Andrew B Rosenkrantz; Stephen M Scionti; Savvas Mendrinos; Samir S Taneja
Journal:  AJR Am J Roentgenol       Date:  2011-07       Impact factor: 3.959

Review 3.  Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.

Authors:  Roger Chou; Jennifer M Croswell; Tracy Dana; Christina Bougatsos; Ian Blazina; Rongwei Fu; Ken Gleitsmann; Helen C Koenig; Clarence Lam; Ashley Maltz; J Bruin Rugge; Kenneth Lin
Journal:  Ann Intern Med       Date:  2011-10-07       Impact factor: 25.391

4.  Lactate MRSI and DCE MRI as surrogate markers of prostate tumor aggressiveness.

Authors:  J Yaligar; S B Thakur; L Bokacheva; S Carlin; H T Thaler; A Rizwan; M E Lupu; Y Wang; C C Matei; K L Zakian; J A Koutcher
Journal:  NMR Biomed       Date:  2011-05-25       Impact factor: 4.044

Review 5.  American Cancer Society guideline for the early detection of prostate cancer: update 2010.

Authors:  Andrew M D Wolf; Richard C Wender; Ruth B Etzioni; Ian M Thompson; Anthony V D'Amico; Robert J Volk; Durado D Brooks; Chiranjeev Dash; Idris Guessous; Kimberly Andrews; Carol DeSantis; Robert A Smith
Journal:  CA Cancer J Clin       Date:  2010-03-03       Impact factor: 508.702

6.  Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging.

Authors:  Marco Auprich; Felix K-H Chun; John F Ward; Karl Pummer; Richard Babaian; Herbert Augustin; Ferdinand Luger; Stefan Gutschi; Lars Budäus; Margit Fisch; Hartwig Huland; Markus Graefen; Alexander Haese
Journal:  Eur Urol       Date:  2010-10-20       Impact factor: 20.096

7.  Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.

Authors:  Akihiro Tanimoto; Jun Nakashima; Hidaka Kohno; Hiroshi Shinmoto; Sachio Kuribayashi
Journal:  J Magn Reson Imaging       Date:  2007-01       Impact factor: 4.813

8.  The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy.

Authors:  Xavier Durand; Evanguelos Xylinas; Camelia Radulescu; Rachel Haus-Cheymol; Stephane Moutereau; Gillaume Ploussard; Aurelien Forgues; Grégoire Robert; Francis Vacherot; Sylvain Loric; Yves Allory; Alain Ruffion; Alexandre de la Taille
Journal:  BJU Int       Date:  2012-01-05       Impact factor: 5.588

9.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

10.  Rethinking screening for breast cancer and prostate cancer.

Authors:  Laura Esserman; Yiwey Shieh; Ian Thompson
Journal:  JAMA       Date:  2009-10-21       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.